ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

RQM+ Acquires Giotto Compliance

RQM+, the world’s leading MedTech service provider, today announced the acquisition of Giotto Compliance from Giotto.ai. Giotto Compliance is a global, all-in-one artificial intelligence (AI) platform designed to increase the efficiency and effectiveness of regulatory reports and filings across the product development lifecycle for medical device and in vitro diagnostics manufacturers.

“We have only begun to scratch the surface of what can be achieved by integrating Giotto Compliance AI technology throughout our consulting, clinical trials, laboratory and reimbursement services,” said RQM+ CEO Margaret Keegan. “We are fortunate to have our Chief Digital and Technology Officer Alaric Jackson lead this new business unit. He will expand the capabilities of Giotto Compliance to enhance our current services as well as offer a standalone solution that can be leveraged to streamline regulatory document development while maintaining compliance with global regulations.”

Giotto Compliance will operate as an independent RQM+ business unit and serve its growing customer base. The business will be led by Jackson, who has more than 20 years of technology leadership experience within the contract research organization (CRO) and pharmaceutical industries. In previous roles, he automated and streamlined regulatory solutions to enhance compliance, productivity and quality using advanced technologies and digital workflows.

“We are excited to offer the MedTech industry a step change using cutting-edge AI that improves quality while increasing speed-to-market,” said Jackson. “Currently, Giotto Compliance reduces the burden of data collection, analysis and creation of regulatory documentation, such as clinical evaluation reports, allowing our team to focus on creative solutions, complex problem solving and impactful work. We will accelerate the creation of AI models and functionality to expand its capabilities across a wide range of processes for MedTech manufacturers, regulators and service providers.”

About RQM+

RQM+ is the leading MedTech service provider with the world’s largest global team of regulatory and quality experts. Building upon 40 years of regulatory expertise, we also provide comprehensive clinical trial, lab and reimbursement services – reducing risk and supporting market access throughout the entire product lifecycle for medical devices, digital therapeutics and diagnostics. With more former FDA, Medicines and Healthcare Products Regulatory Agency (MHRA) and notified body regulators than any other firm, the RQM+ team has deep expertise in all clinical specialties. RQM+ currently works for 19 of the top 20 medical device manufacturers and seven of the top 10 IVD companies. For more information, visit RQMplus.com.

About Giotto.ai

Giotto.ai partners with industry leaders to deliver outstanding cloud products where users collaborate with AI. Thanks to its proprietary platform and strong product management expertise, it facilitates the development of sophisticated, performant and highly customized software products. Giotto.ai, previously known as L2F SA, is headquartered in Lausanne, Switzerland, and counts more than 50 collaborators spread across Switzerland, Italy and Romania.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.19
+0.81 (0.33%)
AAPL  259.58
+0.21 (0.08%)
AMD  207.69
+4.52 (2.22%)
BAC  55.02
-0.83 (-1.48%)
GOOG  328.94
-0.20 (-0.06%)
META  649.02
-4.04 (-0.62%)
MSFT  479.36
+0.08 (0.02%)
NVDA  184.37
-0.49 (-0.27%)
ORCL  204.58
+6.06 (3.05%)
TSLA  447.70
+2.69 (0.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.